Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • mtdsus mtdsus Sep 13, 2012 2:27 PM Flag

    6 years Study shows LOVAZA ineffective in reducing heart attacks.ORIGIN study in NEjournal

    6 years study--Origin-results were published in New England Journal for LOVAZA.It showed that Lovaza is INEFFECTIVE. In an interview by Dr.Payal Kohli with Dr.Deepak Bhatt--talks about this study and over the counter fish oil. Dr.Kohli provides the details of Reduce-It study in progress and JELIS study results.(URL's are provided in the article's URL ://burst.to/eB
    They mention that C-reactive protein (hs-CRP) reduction is important.Lovaza does not lower CRP,but VASCEPA does that in 4 gram/day dosage.
    It seems that VASCEPA should reduce Strokes and heart attacks--when results are available in 2015 or 2016.
    Anyone taking Fish oil or Lovaza might be fooling themselves in believing that it will reduce their Stroke or heart attack risks. Reducing trigylcerides is NOT enough--any drug must also reduce C-rp.

    Sentiment: Strong Buy

 
AMRN
2.35+0.02(+0.86%)Jul 22 4:00 PMEDT